BACKGROUND: Sporotrichosis is a fungal infection caused by Sporothrix schenckii complex, usually restricted to the skin, subcutaneous cellular tissue, and adjacent lymphatic vessels. Antimicrobial photodynamic therapy (aPDT) could be a good alternative to manage localized, superficial infections. CASE REPORT: A 65-year-old African woman was diagnosed with a fixed cutaneous sporotrichosis on her left arm, treated with itraconazol and oral terbinafine with partial improvement. Topical 16% methyl aminolevulinate (MAL, Metvix(®))-PDT was used without success. METHODS: An in vitro photoinactivation test with the isolated microorganism revealed phenothiazinium salts to be more effective than MAL. CONCLUSIONS: PDT with intralesional 1% methylene blue (MB) in combination with intermittent low doses of itraconazole obtained complete microbiological and clinical response.
BACKGROUND:Sporotrichosis is a fungal infection caused by Sporothrix schenckii complex, usually restricted to the skin, subcutaneous cellular tissue, and adjacent lymphatic vessels. Antimicrobial photodynamic therapy (aPDT) could be a good alternative to manage localized, superficial infections. CASE REPORT: A 65-year-old African woman was diagnosed with a fixed cutaneous sporotrichosis on her left arm, treated with itraconazol and oral terbinafine with partial improvement. Topical 16% methyl aminolevulinate (MAL, Metvix(®))-PDT was used without success. METHODS: An in vitro photoinactivation test with the isolated microorganism revealed phenothiazinium salts to be more effective than MAL. CONCLUSIONS: PDT with intralesional 1% methylene blue (MB) in combination with intermittent low doses of itraconazole obtained complete microbiological and clinical response.
Authors: Juliana Pereira Lyon; Leonardo Marmo Moreira; Vanessa Silva Dutra de Carvalho; Fabio Vieira dos Santos; Carlos José de Lima; Maria Aparecida de Resende Journal: Mycoses Date: 2012-07-23 Impact factor: 4.377
Authors: P G Calzavara-Pinton; M Venturini; R Capezzera; R Sala; C Zane Journal: Photodermatol Photoimmunol Photomed Date: 2004-06 Impact factor: 3.135
Authors: Marco Tuccori; Francesco Bresci; Benedetta Guidi; Corrado Blandizzi; Mario Del Tacca; Marco Di Paolo Journal: Ann Pharmacother Date: 2008-06-03 Impact factor: 3.154
Authors: Rosane Orofino-Costa; Dayvison Francis Saraiva Freitas; Andréa Reis Bernardes-Engemann; Anderson Messias Rodrigues; Carolina Talhari; Claudia Elise Ferraz; John Verrinder Veasey; Leonardo Quintella; Maria Silvia Laborne Alves de Sousa; Rodrigo Vettorato; Rodrigo de Almeida-Paes; Priscila Marques de Macedo Journal: An Bras Dermatol Date: 2022-09-22 Impact factor: 2.113
Authors: Ludmila M Baltazar; Anjana Ray; Daniel A Santos; Patrícia S Cisalpino; Adam J Friedman; Joshua D Nosanchuk Journal: Front Microbiol Date: 2015-03-13 Impact factor: 5.640
Authors: Rosane Orofino-Costa; Priscila Marques de Macedo; Anderson Messias Rodrigues; Andréa Reis Bernardes-Engemann Journal: An Bras Dermatol Date: 2017 Sep-Oct Impact factor: 1.896